Genetic Epilepsy Surgery Outcomes in 272 Patients

This explainer reviews genetic epilepsy surgery outcomes in a selected group of people with pathogenic or likely pathogenic germline variants who underwent resection or laser ablation.

Source: Neurology

Summary

What was studied

Researchers studied seizure outcomes after resection or laser ablation in 272 people with pathogenic or likely pathogenic germline genetic variants. People with tuberous sclerosis were excluded.

The study combined a systematic review of MEDLINE (PubMed) and Scopus with additional cases: 224 literature cases from 65 studies, 36 cases from 3 institutional cohorts, and 12 cases from Pediatric Epilepsy Research Consortium databases. Researchers grouped cases by the biological pathway involved in their genetic condition. The main outcome was seizure freedom, classified as Engel I, at the last follow-up. Median follow-up was 24 months, with an interquartile range of 12–48.0 months.

What they found

Seizure freedom differed across genetic groups: vascular disorders, 14/19 (73.6%); GATORopathies, 79/120 (65.8%); copy number variants, 18/31 (58.0%); overgrowth disorders, 9/16 (56.6%); channelopathies, 13/43 (30.0%); synaptopathies, 4/18 (22.2%); and other disorders, 11/25 (44.0%). The overall difference across groups was statistically significant (p < 0.001).

Among cases with available imaging results, 208/253 (82.2%) had an MRI-visible lesion considered to be involved in their epilepsy. Such lesions were present in 64% of channelopathy cases and 80% of synaptopathy cases, despite these groups having lower seizure-freedom rates.

In unadjusted comparisons of each category with all other categories, the odds ratios for seizure freedom were 2.64 for vascular disorders (95% confidence interval 0.87–9.65), 2.41 for GATORopathies (95% confidence interval 1.44–4.09), 0.23 for synaptopathies (95% confidence interval 0.05–0.77), and 0.22 for channelopathies (95% confidence interval 0.09–0.48). The direction and size of the differences remained similar in planned analyses limited to cases with lesions, limited to published cases, or excluding GATORopathies.

Limits of the evidence

This analysis describes selected patients who underwent surgery. It cannot establish whether surgery is better than nonsurgical care for each genetic condition or predict an individual person's outcome. The comparisons were unadjusted, so other differences between groups could help explain the results. Some groups were small, and the vascular-disorder odds estimate was particularly uncertain: its confidence interval included 1, meaning no difference could not be ruled out. Follow-up duration varied, so these results do not establish lifelong seizure freedom. The abstract does not provide the age distribution, detailed results for individual genes or procedures, surgical harms, or effects on development and quality of life.

For families and caregivers

A genetic cause of epilepsy does not automatically mean surgery cannot help. In this selected group, many patients became seizure-free, but outcomes varied substantially by the biological pathway involved. Even among patients with MRI-visible lesions, channelopathies and synaptopathies had lower seizure-freedom rates. These findings may help inform discussions about what genetic results add to the wider presurgical evaluation, but they do not determine an individual person's likely outcome.

What to watch next

Prospective surgical registries that account for genetic diagnoses, use standardized EEG, imaging, and pathology reporting, and track seizure outcomes over time are needed. These could help refine surgical candidate selection and assess outcomes beyond seizures.

Terms in this summary

germline genetic variant: A genetic change that may be inherited or arise for the first time in a person, rather than a change confined to a small area of tissue.
GATORopathies: Genetic disorders affecting the GATOR pathway, which helps regulate cell growth and activity.
copy number variant: A missing or extra section of DNA that can affect one or more genes.
channelopathy: A disorder affecting channels that control the movement of charged particles into and out of cells, helping regulate electrical signals.
synaptopathy: A disorder affecting the connections through which nerve cells communicate.
Engel I: A category for seizure outcome after epilepsy surgery, used here to define seizure freedom.
odds ratio: A measure comparing the odds of an outcome between groups; 1 means equal odds.
95% confidence interval: A range showing uncertainty around an estimate; wider intervals indicate less precision.